Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Jan 7, 2024; 30(1): 79-90
Published online Jan 7, 2024. doi: 10.3748/wjg.v30.i1.79
Table 3 Univariate analysis of severe complications after laparoscopic distal gastrectomy in gastric cancer patients
Variate
No-severe complication (%)
Severe complication (%)
t/χ2
P value
OR
95%CI
Age group
Age ≤ 65239381.9050.168
Age > 65121281.4550.852-2.485
Gender
Male234410.0950.758
Female126251.1320.658-1.948
BMI group
BMI ≤ 28347579.490.002
BMI > 281394.2151.722-10.313
Hb129.7 ± 26.6126.8 ± 26.20.7970.4240.9960.986-1.006
ALB40.7 ± 4.8540.3 ± 4.030.7070.480.980.927-1.036
Tumor size3.2 ± 1.83.5 ± 2.0-1.3460.1791.1010.967-1.266
Bleeding volume103.3 ± 89.2128.6 ± 91.9-2.1090.0361.0031.000-1.005
Operative time230.7 ± 45.1232.4 ± 42.2-0.2820.7781.0010.995-1.007
Blood transfusion6.9 ± 49.8650.00 ± 121.8-27.381< 0.0011.0061.003-1.010
Severe heart disease
No359642.7480.064
Yes1211.2191.002-125.553
Severe lung disease
No358634.6010.032
Yes238.5241.396-52.039
Hypertension
No302550.0130.91
Yes58111.0410.541-2.109
Diabetes
No 329600.0160.899
Yes3161.0610.424-2.654
Surgerical type
Totally 82201.7340.188
Assisted278460.6780.380-1.212
Reconstruction
Billroth I90126.1330.105
Billroth II106261.8400.878-3.854
Roux-en-Y113241.5930.755-3.360
Billroth II + Braun5140.5880.180-19.19
ECOG score
03232795.605< 0.001
134269.1484.804-17.421
231351.84013.913-193.157
ASA score
23535529.802< 0.00110.0863.750-27.124